Hereditary Transthyretin-mediated Amyloidosis with Polyneuropathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-08-19
Clinical Trial Update: TEGSEDI Pregnancy Surveillance Program
Clinical trial update shows a TEGSEDI pregnancy surveillance program for hereditary transthyretin-mediated amyloidosis with polyneuropathy i…